ANTICOAGULANT CIT PHOS DEX ADENINE SOL USP
ANTICOAGULANT CIT PHOS DEX ADENINE SOL USP
Dormant
DIN Number
01960865
Drug Class
Human
Market Date
Oct 17, 1996
Company
HC
baxter corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number01960865
AIG Number0514462001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V07AC BLOOD TRANSFUSION, AUXILIARY PRODUCTS
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification20:12.04.92
Health Canada Classification
ACTIVE INGREDIENTS (5)
ADENINEActive
Strength: 17.3 MG / 63 ML
Monograph: ADENINE
CITRIC ACIDActive
Strength: 189 MG / 63 ML
Monograph: CITRIC ACID
DEXTROSEActive
Strength: 2 G / 63 ML
Monograph: DEXTROSE
SODIUM CITRATEActive
Strength: 1.66 G / 63 ML
Monograph: SODIUM CITRATE
SODIUM PHOSPHATE MONOBASICActive
Strength: 140 MG / 63 ML
Monograph: SODIUM PHOSPHATE MONOBASIC